PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma.
<h4>Background & aims</h4>Aim of this study was to evaluate whether the PNPLA3 I148M polymorphism, previously associated with hepatocellular carcinoma (HCC) risk, influences the clinical presentation of HCC and survival.<h4>Methods</h4>we considered 460 consecutive HCC patients referred to tertiary...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Public Library of Science (PLoS)
2013-01-01
|
| Серии: | PLoS ONE |
| Online-ссылка: | https://doi.org/10.1371/journal.pone.0075982 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
